2,2'- (5- (Bromomethyl) -1,3-phenylene) bis (2-methylpropanenitrile) (Anastrozole Impurity) -d12

1185016-59-4

5- (bromomethyl) -a, a, a', a'-tetramethyl-1,3-benzenediacetonitrile-d12

12352005

Isotope-Labeled Compounds

Others

Others

10 mM in DMSO

C(C#N)(C([2H])([2H])[2H])(C([2H])([2H])[2H])C1=CC(C(C#N)(C([2H])([2H])[2H])C([2H])([2H])[2H])=CC(CBr)=C1

C15H5D12BrN2

317.29

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.

Room temperature

Isotope-Labeled Compounds

No Development Reported